Ricketts, Emily J. http://orcid.org/0000-0002-1633-8618
Swisher, Valerie
Greene, Deanna J.
Silverman, Daniel
Nofzinger, Eric A.
Colwell, Christopher S.
Funding for this research was provided by:
National Institute of Mental Health (K23MH113884)
Tourette Association of America
Brain and Behavior Research Foundation (30464)
Article History
Accepted: 7 November 2022
First Online: 23 January 2023
Declarations
:
: Dr. Ricketts reports grants from the Tourette Association of America, National Institute of Mental Health, and Brain and Behavior Research Foundation, relevant to the submitted work. She also reports grants and personal fees from the Tourette Association of America, grants from National Heart, Lung, and Blood Institute: Programs to Increase Diversity among Individuals in Health-Related Research; personal fees from Centers for Disease Control and Prevention, personal fees from Springer Nature, and service on the Tourette Association of America Diversity Committee, outside the submitted work. Ms. Swisher, Dr. Greene, and Dr. Silverman have nothing to disclose. Dr. Nofzinger reports being the Founder, Inventor, and Chief Medical Office of Ebb Therapeutics (formerly known as Cerêve, Inc.), a company that manufactured devices to administer frontal cerebral thermal therapy for insomnia, relevant to the submitted work and outside the submitted work. In addition, Dr. Nofzinger has multiple patents related to the frontal cerebral thermal therapy device, with royalties received on University of Pittsburgh license to Ebb Therapeutics. Dr. Colwell reports unpaid consulting for RealSleep™, outside the submitted work.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).